Can anyone explain the following anomaly?
The new partner at Forbes (Livingstone) only paid US$830,000 for a 50% share and they need to pay 50% costs going forward. Therefore, the current market value of Forbes (as a project) is US$1.66 million. At an exchange rate of 74c, the equates to AU$ 2.24 million or 1.3 cents per share.
However, the remaining 50% interest in Forbes is valued at $300-350 million and is reported to have an potential impact of $1.60 on the share price (taken from the investor presentation).
Who is this unlisted Australian company who paid AU$ 1.2 million for an asset worth $300-350 million? Obviously the cash was unimportant at this time.
Incidentally, OPL purchased 50% of Forbes from Matris for US$600,000 on 16 May 2005, and received as a bonus, a 25% interest in NW Rio Vista (valued at AU$ 240,000 in the presentation).
I there anyone out there who is so good at Maths they can follow this logic?
- Forums
- ASX - By Stock
- OPL
- valuation vs sell price
OPL
opyl limited
Add to My Watchlist
6.90%
!
2.7¢

valuation vs sell price
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
2.7¢ |
Change
-0.002(6.90%) |
Mkt cap ! $6.344M |
Open | High | Low | Value | Volume |
2.8¢ | 2.8¢ | 2.7¢ | $7.778K | 280.4K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 964558 | 2.7¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
2.8¢ | 299970 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 964558 | 0.027 |
3 | 1860588 | 0.026 |
2 | 1200000 | 0.025 |
1 | 41666 | 0.024 |
2 | 130000 | 0.023 |
Price($) | Vol. | No. |
---|---|---|
0.028 | 299970 | 1 |
0.029 | 185196 | 1 |
0.030 | 461010 | 2 |
0.031 | 495387 | 2 |
0.034 | 29441 | 1 |
Last trade - 16.10pm 04/07/2025 (20 minute delay) ? |
Featured News
OPL (ASX) Chart |
The Watchlist
NUZ
NEURIZON THERAPEUTICS LIMITED
Dr Michael Thurn, CEO & MD
Dr Michael Thurn
CEO & MD
SPONSORED BY The Market Online